Nutraceutical International Corp (NUTR) financial statements (2021 and earlier)

Company profile

Business Address 1400 KEARNS BOULEVARD
PARK CITY, UT 84060
State of Incorp. DE
Fiscal Year End September 30
SIC 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

6/30/2017
Q3
3/31/2017
Q2
12/31/2016
Q1
9/30/2016
Q4
6/30/2016
Q3
3/31/2016
Q2
12/31/2015
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments4667445
Cash and cash equivalents4667445
Receivables21211818211918
Inventory, net of allowances, customer advances and progress billings69656664646162
Inventory69656664646162
Deferred tax assets1111111
Other undisclosed current assets6444344
Total current assets:101979694939091
Noncurrent Assets
Property, plant and equipment82828283838378
Intangible assets, net (including goodwill)67515253545556
Goodwill39313131313131
Intangible assets, net (excluding goodwill)28202122232425
Other noncurrent assets1111222
Deferred tax assets, net5544553
Total noncurrent assets:155140140142144145139
TOTAL ASSETS:256237236236237235229
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities23202020212118
Accounts payable16151613141413
Accrued liabilities7557774
Total current liabilities:23202020212118
Noncurrent Liabilities
Long-term debt and lease obligation51374044464848
Long-term debt, excluding current maturities51374044464848
Liabilities, other than long-term debt1000000
Other liabilities1000000
Total noncurrent liabilities:51374044464848
Total liabilities:74576064676866
Stockholders' equity
Stockholders' equity attributable to parent182180176172169166163
Common stock0000000
Treasury stock, value    (0)(0) 
Additional paid in capital2210146
Accumulated other comprehensive loss(0)(1)(1)(0)(1)(0)(0)
Retained earnings180179175172169162158
Total stockholders' equity:182180176172169166163
TOTAL LIABILITIES AND EQUITY:256237236236237235229

Income statement (P&L) ($ in millions)

6/30/2017
Q3
3/31/2017
Q2
12/31/2016
Q1
9/30/2016
Q4
6/30/2016
Q3
3/31/2016
Q2
12/31/2015
Q1
Revenues
(Revenue, Net)
65615757615956
Cost of revenue
(Cost of Goods and Services Sold)
(32)(30)(28)(29)(29)(29)(28)
Gross profit:33312928313028
Operating expenses(29)(24)(22)(22)(23)(23)(21)
Operating income:4776987
Interest and debt expense(0)(0)(0)(0)(0)(0)(0)
Income from continuing operations before income taxes:4766877
Income tax expense(2)(2)(2)(2)(2)(3)(2)
Net income available to common stockholders, diluted:2444654

Comprehensive Income ($ in millions)

6/30/2017
Q3
3/31/2017
Q2
12/31/2016
Q1
9/30/2016
Q4
6/30/2016
Q3
3/31/2016
Q2
12/31/2015
Q1
Net income:2444654
Comprehensive income:2444654
Other undisclosed comprehensive income (loss), net of tax, attributable to parent00(0)0(0)0(0)
Comprehensive income, net of tax, attributable to parent:2444654

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: